Covid Report: Small Biotech Surges On Plan To Test Vaccine In May

Covid Report: Small Biotech Surges On Plan To Test Vaccine In May

Novavax stock popped Wednesday after the small biotech company said it plans to begin human testing of its coronavirus vaccine in mid-May. The company expects preliminary results in July.